Supreme Court Takes Up Drug Company Dispute

Posted: Updated:

WASHINGTON (AP) — The Supreme Court is wading into a patent dispute between rival pharmaceutical companies over a multiple sclerosis treatment.

The justices agreed Monday to hear an appeal from Teva Pharmaceutical Industries Ltd., which claims the U.S. Court of Appeals for the Federal Circuit wrongly overturned five of its patents for the drug Copaxone.

The appeals court ruling would allow rivals Mylan Inc., Momenta Pharmaceuticals Inc. and Sandoz, Inc., to start selling generic versions of the drug later this year, after the remaining patents on the drug expire.

A federal district court had earlier ruled in Teva's favor and upheld the patents. Teva says the Federal Circuit should have deferred to factual findings made in the district court.

The justices will hear the case in the fall.

Also on HuffPost:

Supreme Court Justices
Share this
Current Slide

Suggest a correction

Around the Web

Supreme Court relaxes mandatory drug-dealer sentencing in ...

Drug Companies Win Two Supreme Court Decisions -

Supreme Court Rejects Overtime Pay for Drug Reps -

On Access and Accountability — Two Supreme Court Rulings on ...

Supreme Court: Generic-drug makers can't be sued under state law ...

Justices block generic drug liability lawsuits | Reuters

Problem Solving Courts | Supreme Court - Idaho State Judiciary

Supreme Court Takes up Drug Company Dispute

Texas Supreme Court Halts Release of Drug Supplier

Texas Supreme Court withholds identity of execution drug supplier

US Drug Cases Getting Rehabbed After Supreme Court Decision

US top court takes no action in Teva MS drug case

SD Supreme Court Hears Drug Possession Case

SD Supreme Court case could alter state drug law